Fresenius Medical Financials

Please note, the presentation of Fresenius Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Fresenius Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Fresenius Medical's management manipulating its earnings.

Fresenius Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Fresenius Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The output start index for this execution was nine with a total number of output elements of fifty-two. The Beta measures systematic risk based on how returns on Fresenius Medical Care correlated with the market. If Beta is less than 0 Fresenius Medical generally moves in the opposite direction as compared to the market. If Fresenius Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fresenius Medical Care is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fresenius Medical is generally in the same direction as the market. If Beta > 1 Fresenius Medical moves generally in the same direction as, but more than the movement of the benchmark.